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This thesis describes a number of research projects in primary healthcare in the
Netherlands. Subject of study is how pharmacists and general practitioners (GPs)
collaborate to achieve more rational drug use. 'More rational drug use', here, also means
'safer drug use': each drug is safe as long as it is used appropriately. ln the Netherlands the
-currently unique- situation exists that virhrally all GPs and pharmacists participate in peer
review or audit meetings. These are meetings between relatively small groups of
pharmacists and GPs that discuss a wide variety of aspects to do with drug use. The
frequency varies: some groups have monthiy meetings and other groups meet twice ayear.
Peer review and audit meetings led to the research presented in this thesis.
Chapter one, the introduction, describes two aspects. $ 1.1 looks back in time. How has the
collaboration between pharmacists and physicians evolved; what do peer review meetings
originate from? Over the centuries, 'the pharmacist' has evolved from a sub-specialty of
medicine to its own academic profession. From $ 1.1 we see that there always has been
some kind of collaboration between physicians and pharmacists. In some places in the
Netherlands, intensive collaboration behveen the two professions evolved already in the
16tr' century. However, over the centuries, the relationship between physicians and
pharmacists can be seen as a 'love-hate relationship', in which the two professions
continuously irritated each other because they intruded on each other's territory. Each felt
threatened by the other and at the same time the professions needed each other to provide
good patient care.
Here, the expression 'it takes two to tango' comes to mind. This expression means as much
as 'optimal collaboration needs commitment from both' and this metaphor seems very
appropriate for the situation. In the beginning, partners step on each other's toes a lot. In
the end, it can be great fun to dance the tango 'as one' in a ballroom full of tango dancers.
In the same way, good collaboration between pharmacists and physicians can lead to safer
drug use. If both professions collaborate well in their aim to achieve rational drug use, this
will lead to safer drug use, hence better patient care.
$1.2 provides a broader perspective: internationally, how do various professions aim for
safer drug use, and who are responsible? To aim for safer drug use in fact means changing
behaviour: behavioural change for instance by the drug prescriber or dispenser, or the
patient. This section provides an overview of methods that are available to help achieve
such changes in behaviour.
Although virtually all pharmacists and GPs participate in peer review or audit, clearly the
various groups have different interpretations of this fype of meeting. Also, the groups
expressed a need for overviews of prescribing behaviour: how effective were the meetings
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in changing prescribing behaviour? And can the confrontation with one's own prescribing
behaviour be an impulse to change that behaviour? Can it be stimulating to see that
colleague prescribers demonstrate different behaviour? In $2.1 the various possibilities are
discussed in which feedback on prescribing can be given, depending on the aims.
Most prescription data are stored in the pharmacy's computer system. However, to use
these data to generate overviews of prescribing was quite complicated. Therefore, the
Social Pharmacy & Pharmacoepidemiology roup in Groningen have developed a
computer program that generates uch overviews. This program is called AFTO (Analyse
voor FqrmqcoTherapie Overleg -in English: analysis for peer review meetings). It enables
pharmacists to make graphic overviews of which drugs have been dispensed to how many
patients for which GPs. $2.2 describes the development and nation-wide application of the
AFTO program.
The AFTO program provides more possibilities than just making graphs. AFTO organises
the pharmacy data in such a way that it facilitates the conduct of advanced rug utilisation
studies and various pharmacoepidemiological studies. An example is given in $2.4, a study
ofchanges in prescribing ofthird generation oral contraceptives. In October 1995, studies
were published that demonstrated an association between use of third generation oral
contraceptives and the occurrence of deep vein thrombosis. $2.4 shows that after this 'pill
scare', especially in the youngest age group, third generation oral contraceptives were used
less. Furthermore, we saw no panic reaction: people did not suddenly all switch from third
to second generation oral contraceptives. However, after October 1995, whenwomen
switched from one oral contraceptive to another, chances were higher that this was a
second generation oral contraceptive, than before October 1995. For S2.3 (the development
of a model to select people who are eligible for an influenza vaccination) we also used the
AFTO program, and also for a study that has been published but not incorporated in this
thesisr. As a result, chapter 2 is a chapter that describes how the use of pharmacy data in
several stages of drug utilisation review can support more rational drug use.
In chapter 3, peer review meetings are discussed in-depth. In the Netherlands, 45 peer
review groups were willing to participate in a study of the state of the ar1 and effectiveness
of peer review meetings. To gain insight in the process of these 45 groups' meetings, we
developed a questionnaire: was the meeting considered useful, have the participants leamt
anything from it, and how did communication processes between the participants evolve?
The factor analysis that is described in $3.1 distinguishes two factors: relational aspects
between group members and structure and contents of the meeting.
Fufthermore, of all these groups a pharmacist and a GP were interviewed with respect o
various aspects of their peer review meetings. Because we did not expect hese 45 groups
to be representative of all peer review groups in the Netherlands we have also held a
questionnaire survey among a random sample of 880 GPs. The combination of interviews












































































conduct their meetings and the follow up of these meetings. Also, satisfaction with peer
review differs; this varies from 'a waste of time' to 'the main source of postgraduate
education'. A general conclusion is that the pharmacist contributes more to peer review
than the GP (S3.2).
Next to general aspects of peer review, the survey among GPs focused on GPs' knowledge
of common guidelines for rational drug use. There are information sources exist publish
such guidelines, and which GPs use a lot in the preparation of peer review meetings (Dutch
l,trqtional Formulary, or 'Farmacotherapeutisch Kompas'; GP guidelines or 'NHG
Standaarden', and the Drug Bulletin or 'Geneesmiddelenbulletin'). From the suryey, we
know to what extent GPs state that they prescribe according to these guidelines: the suruey
reflects reporled behaviour. The results do not demonstrate any correlation between
participation in peer review and repofied prescribing behaviour according to national
guidelines. As virtually everyone participates in peer review meetings, this is not
surprising. However, GPs who were more content with theiÍ peer review meetings, on
average had a better score on this questionnaire ofreported behaviour. Another result is
that in general, results were less positive than we expected: only 37oÁ of the GPs had an
overall score on the list that indicated general adherence to the national guidelines ($3.3)
Another issue that became apparent in this study was the influence that specialists'
prescribing has on the feasibility of agreements that are made during peer review meetings.
Generally, specialists do not participate in primary care peer review meetings. $3.4
demonstrates to what extent specialists' prescribing influences GPs' prescribing of some
cardiovascular drugs. Sixty-five percent of these drugs were initiated by specialists, which
indicates that this is indeed a factor that may hamper making agreements about this drug
group.
Finally, $3.5 gives a longitudinal analysis of the effects of peer review meetings on
prescribing and dispensing behaviour: 33 meetings were evaluated and for 45Yo of them, a
statistically significant effect could be demonstrated. In general, the effects are not very
large. The effectiveness of peer review seems to be achieved sooner when the meetings are
supported by continuous feedback on prescribing, by lists with patient names for whom the
agreements involve a necessary change in drug use, and when the agreements are clear,
unequivocal, and relatively easy to follow up.
Chapter 4 places the research presented in this thesis in a broader perspective. In many
ways, the Dutch situation shows parallels with the situation in other countries. On top of
that, peer review groups in the Netherlands have opportunities -because of the
organisation of healthcare, because of the relatively small distances in this country, and
because of the organisation of pharrnacy data- that are unique in the world. We urge to
make optimal use of those possibilities, as described in the thesis. Fufthermore, we suggest
the need to train clinical insight of pharmacy students, the option of pharmacists and GPs
to have a short training period in each other's practices during their pre-registration
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training, and the potential benefits of a more intensive collaboration between university
and practice to achieve more rational -hence, safer- drug use.
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